Return to Statistics Toolbox

Volcano Plot analysis for Study ST003436

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:FBS-based standard | Sample Type:FBS-based standard | Drug Treatment:NA | Time post-injection:NA (24)
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:15 min (3)
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:1 h (3)
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:2 h (3)
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:3 h (3)
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:4 h (3)
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:6 h (3)
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:Control | Time post-injection:NA (3)
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:15 min (3)
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:1 h (3)
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:2 h (3)
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:3 h (3)
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:4 h (3)
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:6 h (3)
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:Control | Time post-injection:NA (3)
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:15 min (3)
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:1 h (3)
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:2 h (3)
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:3 h (3)
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:4 h (3)
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:6 h (3)
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:Control | Time post-injection:NA (3)
Sample source:Murine plasma | Sample Type:Plasma-based standard | Drug Treatment:NA | Time post-injection:NA (14)
Sample source:Murine plasma | Sample Type:Plasma | Drug Treatment:NA | Time post-injection:NA (19)
Sample source:NA | Sample Type:Blank | Drug Treatment:NA | Time post-injection:NA (5)
Sample source:NA | Sample Type:QC | Drug Treatment:NA | Time post-injection:NA (2)
Sample source:QC | Sample Type:QC | Drug Treatment:NA | Time post-injection:NA (1)
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Group by metabolite classification:    Use:
Maximum # of (most significant) metabolites per class to use in pvalue group calculation:
Analysis:Combine data for all analyses?:     

  logo